Program
Faculty
Program
Faculty
Early treatment and relapse, relevant biomarkers & pathology
Back
Saturday May 25, 2024 from 13:45 to 16:00
Room: Imperial
> SYMP-3.5 MIRASOL: Phase III trial on MRIV (antibody drug congugate for FR-alpha high platinum resistant OvCa)
Log in to add to favorites
Add Personal Notes
Kathleen Moore
Professor
Gynecological Oncology
University of Oklahoma
Presentations by Kathleen Moore
Sat-25 from 13:45 - 16:00 in room Imperial
Early treatment and relapse, relevant biomarkers & pathology
MIRASOL: Phase III trial on MRIV (antibody drug congugate for FR-alpha high platinum resistant OvCa)
Email:
info@ccocr.org
514-373-4800 x103
© 2024 CCOCR 2024
